Haleon PLC (HLN)
8.275
+0.08
(+1.04%)
USD |
NYSE |
May 09, 16:00
8.275
0.00 (0.00%)
After-Hours: 19:44
Haleon Price: 8.275 for May 9, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 08, 2024 | 8.30 | 8.31 | 8.12 | 8.19 | 7.063M |
| May 07, 2024 | 8.31 | 8.340 | 8.26 | 8.33 | 5.295M |
| May 06, 2024 | 8.29 | 8.36 | 8.14 | 8.24 | 6.076M |
| May 03, 2024 | 8.39 | 8.40 | 8.29 | 8.30 | 11.74M |
| May 02, 2024 | 8.28 | 8.44 | 8.275 | 8.32 | 9.938M |
| May 01, 2024 | 8.37 | 8.41 | 8.275 | 8.35 | 3.540M |
| Apr 30, 2024 | 8.56 | 8.635 | 8.48 | 8.53 | 6.439M |
| Apr 29, 2024 | 8.45 | 8.48 | 8.41 | 8.47 | 2.491M |
| Apr 26, 2024 | 8.38 | 8.485 | 8.38 | 8.45 | 2.893M |
| Apr 25, 2024 | 8.32 | 8.42 | 8.31 | 8.40 | 2.270M |
| Apr 24, 2024 | 8.41 | 8.42 | 8.31 | 8.35 | 5.161M |
| Apr 23, 2024 | 8.37 | 8.44 | 8.36 | 8.41 | 3.076M |
| Apr 22, 2024 | 8.22 | 8.365 | 8.20 | 8.36 | 3.991M |
| Apr 19, 2024 | 8.16 | 8.22 | 8.145 | 8.22 | 3.638M |
| Apr 18, 2024 | 8.09 | 8.14 | 8.06 | 8.13 | 4.770M |
| Apr 17, 2024 | 8.08 | 8.12 | 8.04 | 8.11 | 3.621M |
| Apr 16, 2024 | 8.07 | 8.145 | 8.06 | 8.10 | 5.210M |
| Apr 15, 2024 | 8.14 | 8.17 | 8.030 | 8.06 | 4.763M |
| Apr 12, 2024 | 8.14 | 8.17 | 7.99 | 8.01 | 7.844M |
| Apr 11, 2024 | 8.19 | 8.22 | 8.145 | 8.17 | 7.065M |
| Apr 10, 2024 | 8.19 | 8.23 | 8.14 | 8.17 | 4.071M |
| Apr 09, 2024 | 8.28 | 8.30 | 8.22 | 8.29 | 4.365M |
| Apr 08, 2024 | 8.27 | 8.29 | 8.21 | 8.22 | 5.329M |
| Apr 05, 2024 | 8.26 | 8.35 | 8.23 | 8.29 | 6.192M |
| Apr 04, 2024 | 8.30 | 8.36 | 8.22 | 8.23 | 4.001M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.63
Minimum
Sep 02 2022
9.00
Maximum
Apr 20 2023
7.867
Average
8.17
Median
Feb 13 2023
Price Benchmarks
| Pfizer Inc | 28.20 |
| GSK PLC | 44.68 |
| AstraZeneca PLC | 77.61 |
| Verona Pharma PLC | 14.75 |
| Adaptimmune Therapeutics PLC | 1.135 |
Price Related Metrics
| PE Ratio | 27.87 |
| PS Ratio | 2.705 |
| PEG Ratio | 8.856 |
| Price to Book Value | 1.786 |
| Earnings Yield | 3.59% |
| Market Cap | 37.78B |
| PEGY Ratio | 5.566 |
| Operating PE Ratio | 14.98 |
| Normalized PE Ratio | 28.07 |